BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36265653)

  • 1. Single-cell RNA sequencing unveils the communications between malignant T and myeloid cells contributing to tumor growth and immunosuppression in cutaneous T-cell lymphoma.
    Du Y; Cai Y; Lv Y; Zhang L; Yang H; Liu Q; Hong M; Teng Y; Tang W; Ma R; Wu J; Wu J; Wang Q; Chen H; Li K; Feng J
    Cancer Lett; 2022 Dec; 551():215972. PubMed ID: 36265653
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single-Cell Lymphocyte Heterogeneity in Advanced Cutaneous T-cell Lymphoma Skin Tumors.
    Gaydosik AM; Tabib T; Geskin LJ; Bayan CA; Conway JF; Lafyatis R; Fuschiotti P
    Clin Cancer Res; 2019 Jul; 25(14):4443-4454. PubMed ID: 31010835
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dimethyl fumarate restores apoptosis sensitivity and inhibits tumor growth and metastasis in CTCL by targeting NF-κB.
    Nicolay JP; Müller-Decker K; Schroeder A; Brechmann M; Möbs M; Géraud C; Assaf C; Goerdt S; Krammer PH; Gülow K
    Blood; 2016 Aug; 128(6):805-15. PubMed ID: 27268084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reprogramming of PD-1+ M2-like tumor-associated macrophages with anti-PD-L1 and lenalidomide in cutaneous T cell lymphoma.
    Han Z; Wu X; Qin H; Yuan YC; Schmolze D; Su C; Zain J; Moyal L; Hodak E; Sanchez JF; Lee PP; Feng M; Rosen ST; Querfeld C
    JCI Insight; 2023 Jul; 8(13):. PubMed ID: 37427589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the Effect of Gentian Violet on Apoptosis and Proliferation in Cutaneous T-Cell Lymphoma in an In Vitro Study.
    Wu J; Wood GS
    JAMA Dermatol; 2018 Oct; 154(10):1191-1198. PubMed ID: 30167641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insights Into the Molecular and Cellular Underpinnings of Cutaneous T Cell Lymphoma.
    Yumeen S; Girardi M
    Yale J Biol Med; 2020 Mar; 93(1):111-121. PubMed ID: 32226341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-cell transcriptomics links malignant T cells to the tumor immune landscape in cutaneous T cell lymphoma.
    Liu X; Jin S; Hu S; Li R; Pan H; Liu Y; Lai P; Xu D; Sun J; Liu Z; Gao Y; Zhao Y; Liu F; Xiao Y; Li Y; Wen Y; Chen Z; Xu B; Lin Y; Ran M; Li Q; Yang S; Li H; Tu P; Haniffa M; Teichmann SA; Bai F; Wang Y
    Nat Commun; 2022 Mar; 13(1):1158. PubMed ID: 35241665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulating constitutive activation of the NF-kappaB canonical pathway overcomes the resistance of cutaneous T-cell lymphoma to apoptosis.
    Sors A; Jean-Louis F; Pellet C; Laroche L; Dubertret L; Courtois G; Bachelez H; Michel L
    Blood; 2006 Mar; 107(6):2354-63. PubMed ID: 16219794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PAK1 overexpression promotes cell proliferation in cutaneous T cell lymphoma via suppression of PUMA and p21.
    Wang Y; Gu X; Li W; Zhang Q; Zhang C
    J Dermatol Sci; 2018 Apr; 90(1):60-67. PubMed ID: 29307600
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combined inhibition of Bcl-2 and NFκB synergistically induces cell death in cutaneous T-cell lymphoma.
    Froehlich TC; Müller-Decker K; Braun JD; Albrecht T; Schroeder A; Gülow K; Goerdt S; Krammer PH; Nicolay JP
    Blood; 2019 Aug; 134(5):445-455. PubMed ID: 31167801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous T cell lymphoma: the helping hand of dendritic cells.
    Edelson RL
    Ann N Y Acad Sci; 2001 Sep; 941():1-11. PubMed ID: 11594563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis.
    Miyagaki T; Sugaya M; Suga H; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):e60-7. PubMed ID: 22404649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma.
    Miyagaki T; Sugaya M; Suga H; Morimura S; Ohmatsu H; Fujita H; Asano Y; Tada Y; Kadono T; Sato S
    J Invest Dermatol; 2012 Apr; 132(4):1280-9. PubMed ID: 22297640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Blockade of the Immune Checkpoint CD47 by TTI-621 Potentiates the Response to Anti-PD-L1 in Cutaneous T-Cell Lymphoma.
    Han Z; Wu X; Qin H; Yuan YC; Zain J; Smith DL; Akilov OE; Rosen ST; Feng M; Querfeld C
    J Invest Dermatol; 2023 Aug; 143(8):1569-1578.e5. PubMed ID: 36863449
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic landscape of cutaneous T cell lymphoma.
    Choi J; Goh G; Walradt T; Hong BS; Bunick CG; Chen K; Bjornson RD; Maman Y; Wang T; Tordoff J; Carlson K; Overton JD; Liu KJ; Lewis JM; Devine L; Barbarotta L; Foss FM; Subtil A; Vonderheid EC; Edelson RL; Schatz DG; Boggon TJ; Girardi M; Lifton RP
    Nat Genet; 2015 Sep; 47(9):1011-9. PubMed ID: 26192916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of IkappaB kinase subunit 2 in cutaneous T-cell lymphoma down-regulates nuclear factor-kappaB constitutive activation, induces cell death, and potentiates the apoptotic response to antineoplastic chemotherapeutic agents.
    Sors A; Jean-Louis F; Bégué E; Parmentier L; Dubertret L; Dreano M; Courtois G; Bachelez H; Michel L
    Clin Cancer Res; 2008 Feb; 14(3):901-11. PubMed ID: 18245554
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New Molecular and Biological Markers in Cutaneous T Cell Lymphoma: Therapeutic Implications.
    Luna DE; Shinohara MM
    Curr Hematol Malig Rep; 2023 Jun; 18(3):83-88. PubMed ID: 37017872
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proapoptotic and antiapoptotic markers in cutaneous T-cell lymphoma skin infiltrates and lymphomatoid papulosis.
    Nevala H; Karenko L; Vakeva L; Ranki A
    Br J Dermatol; 2001 Dec; 145(6):928-37. PubMed ID: 11899146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bortezomib inhibits expression of TGF-β1, IL-10, and CXCR4, resulting in decreased survival and migration of cutaneous T cell lymphoma cells.
    Chang TP; Poltoratsky V; Vancurova I
    J Immunol; 2015 Mar; 194(6):2942-53. PubMed ID: 25681335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ectopic expression of B-lymphoid kinase in cutaneous T-cell lymphoma.
    Krejsgaard T; Vetter-Kauczok CS; Woetmann A; Kneitz H; Eriksen KW; Lovato P; Zhang Q; Wasik MA; Geisler C; Ralfkiaer E; Becker JC; Ødum N
    Blood; 2009 Jun; 113(23):5896-904. PubMed ID: 19351960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.